Rapid Control of Psychotic Excitement States with Intramuscular Haloperidol
Abstract
The authors conducted an open clinical trial of high doses of parenteral haloperidol in the treatment of 40 acutely excited psychotic inpatients. Their preliminary results suggest that intramuscular haloperidol in doses up to 60 mg. a day is safe, effective, and well tolerated in the management of such patients. Adverse reactions, which were infrequent, included extrapyramidal symptoms, lethargy, and, in one patient, transient hypotension.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).